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Abstract
Background—Craniosynostosis is a condition that includes the premature fusion of one or 
multiple cranial sutures. Among various craniosynostosis forms, midline sagittal nonsyndromic 
craniosynostosis (sNSC) is the most prevalent. Although different gene mutations have been 
identified in some craniosynostosis syndromes, the etiology of sNSC remains largely unknown.
Corresponding author: Dr. Ethylin Wang Jabs, Correspondence address: Department of Genetics and Genomic Science, Icahn School 
of Medicine at Mount Sinai, New York, NY, 10029, USA, Phone: (212)241-3504, Fax: (212)849-2508, ethylin.jabs@mssm.edu. 
The abstract has been presented at the Society for Craniofacial Genetics and Developmental Biology Annual Meeting and the 
American Society of Human Genetics 61st Annual Meeting in October 2011, at Montreal, Canada
Full Financial Disclosure
None of the authors has a financial interest in any of the products, devices, or drugs mentioned in this manuscript.
Authors’ contribution
XY and AG performed mutation screening. XY, BR, IP, YH and JR analyzed data. DJF, RJ and PAR collected clinical cases. XY, 
EWJ and PAR drafted the manuscript. EWJ and PAR conceived and designed the study, coordinated and oversaw the project.
Statement of Ethical approval
Written informed consents were obtained from the parents or guardians of the patient. The study protocol was approved by the Icahn 
School of Medicine at Mount Sinai and the University of Iowa and New York State Department of Health institutional review boards, 
and conformed to the guidelines set forth by the Declaration of Helsinki.
HHS Public Access
Author manuscript
Plast Reconstr Surg. Author manuscript; available in PMC 2017 March 01.
Published in final edited form as:
Plast Reconstr Surg. 2016 March ; 137(3): 952–961. doi:10.1097/01.prs.0000479978.75545.ee.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Methods—To screen for candidate genes for sNSC, we performed Sanger sequencing on DNA 
from 93 sNSC patients from a population-based, case-control study conducted in Iowa and New 
York states. FGFR1-3 mutational hotspots known to be associated with sNSC, and the entire 
TWIST1, RAB23, BMP2 coding regions were screened because of their known roles in human 
nonsyndromic or syndromic sagittal craniosynostosis, expression patterns, and/or animal model 
studies.
Results—We identified two rare variants in our cohort. An insertion c.730_731insG in FGFR1, 
which led to a premature stop codon, was predicted to abolish the entire IgIII domain, including 
the ligand binding region. A c.439C>G variant was observed in TWIST1 at its highly conserved 
loop domain in another patient. The patient’s mother harbored the same variant and was reported 
to have jaw abnormalities. These two variants were not detected in 116 alleles from unaffected 
controls or seen in the several databases; however, TWIST1 variant was found in a low frequency 
of .000831 percent in ExAC database.
Conclusions—The low mutation detection rate indicates that these genes only account for a 
very small proportion of sNSC patients. Our results add to the perception that sNSC is a complex 
developmental defect with considerable genetic heterogeneity.
INTRODUCTION
Craniosynostosis is defined by the premature fusion of one or more cranial sutures and the 
malformation of cranial bones that result in abnormal skull shape. It is one of the most 
common birth defects, occurring in 1 per 2,000 to 2,500 live births. Craniosynostosis 
patients are often classified according to the suture(s) involved and whether the cranial vault 
features occur as an isolated defect (nonsyndromic form), or are associated with other facial, 
specific limb, or dermatological features as part of a syndrome (syndromic form). 
Nonsyndromic craniosynostosis (NSC) typically involves premature closure of a single 
suture, the most frequent type being sagittal, and it is controversial whether it is followed by 
the coronal (unicoronal being more frequent than bicoronal synostosis) or the metopic 
suture.1
The premature fusion of the sagittal suture results in an increase of the anteroposterior 
direction of the skull, particularly the calvarium, with growth restriction in the transverse 
direction, causing a narrow, elongated, boat-shaped skull deformity (dolichocephaly or 
scaphocephaly) and varying degrees of frontal bossing and occipital bossing. Abnormal 
growth of the skull can subsequently lead to increased intracranial pressure that can be 
associated with changes in brain morphology, which in turn can contribute to visual 
impairment and neurocognitive deficiency.2,3 The treatment of sagittal craniosynostosis is 
currently evolving. Total vault remodeling (CVR) has been effective for correcting cranial 
shape and expanding intracranial volume. Minimally invasive techniques, such as 
endoscopic suture release, spring assisted surgery, and distraction osteogenesis have been 
used in an effort to potentially reduce surgical morbidity.4
Sagittal nonsyndromic craniosynostosis (sNSC) accounts for approximately one-half of all 
affected patients and shows a strong male predominance (male:female ratio of 3.5:1).5 
Segregation analysis indicates that sNSC follows an autosomal dominant inheritance with a 
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reduced penetrance in only 6% of cases.5 The majority of sNSC is thought to be sporadic. 
The current genetic understanding suggests that the underlying etiology of sNSC is complex, 
most likely involving both genetic and environmental exposures (broadly defined).6 In the 
past two decades, intensive investigations among the more than 180 craniosynostosis 
syndromes have provided valuable insights into identifying genes involved in calvarial 
suture development.7 Among the identified syndromic-causing genes, some are responsible 
for rare syndromes with midline sagittal or multiple suture craniosynostosis (Table 1). 
Heterozygous gain-of-function mutation hotspots in fibroblast growth factor receptors 1, 2 
and 3 (FGFR1, FGFR2, FGFR3) account for most of the common craniosynostosis 
syndromes, including Apert, Crouzon, Pfeiffer, Jackson-Weiss, Beare-Stevenson and 
Muenke syndrome.8 In addition to those FGFR-related craniosynostosis syndromes, 
mutations in several transcription factors such as TWIST1 and MSX2 have been implicated in 
Saethre-Chotzen syndrome and Boston-type craniosynostosis respectively. The clinical 
phenotypes of these syndromes vary greatly, but all have coronal suture involvement. In 
contrast to the increasing number of human genes associated with syndromic 
craniosynostosis,8 only variants in a small number of genes, FGFR1-3, TWIST1, ALX4, 
ERF, IGF1R, and LRIT3 (Table 2) have been reported in sNSC patients. The mutation 
hotspots that are important for syndromic craniosynostosis, FGFR1 exon IIIa, FGFR2 exons 
IIIa and IIIc, FGFR3 exon IIIa, and TWIST1 exon 1 and their somatic changes, have been 
less likely to be associated with sNSC,2,3,9,10 perhaps because the sagittal suture is 
infrequently closed prematurely in syndromic patients. As such, patients with nonsyndromic 
unilateral or bilateral coronal synostosis merit the genetic testing of mutation hotspots in 
FGFR1-3 and TWIST1, but mutation testing is not proposed for patients with sNSC unless a 
syndromic association is suspected due to familial recurrence.3,10 With regard to sNSC, a 
genome-wide association study (GWAS) showed significant association in a 120kb region 
downstream of BMP2 and within a 167kb region of BBS9 in 130 non-Hispanic white case-
parent trios (N=130) and replicated in 172 case-controls of the same ethnicity, but without 
identifying plausible causative mutations.11
To further investigate the pathogenesis of sNSC, we sequenced known FGFR1-3 and 
TWIST1 mutations that were found to be related to sNSC (Table 2) and two new candidate 
genes RAB23 and BMP2 using case-parent trio specimens from families identified from two 
population-based birth defect surveillance programs in the U.S.
MATERIALS AND METHODS
Study Population and Data Collection
Cases were live born children with a diagnosis of single suture, sagittal craniosynostosis 
born from January 1, 1998 through December 31, 2008 to resident mothers in Iowa or New 
York State. Cases were enumerated from the Iowa Registry for Congenital and Inherited 
Disorders and the New York State Congenital Malformations Registry, two population-
based birth defect surveillance programs. Controls were live children born without a major 
birth defect diagnosis to resident mothers in Iowa or New York State during the same time 
frame as cases and frequency matched by birth year to cases. To be eligible for recruitment, 
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a case or control mother needed to be able to complete an English language questionnaire 
and to have custody of the case or control child.
Data collection was conducted in three phases: family history questionnaire, saliva specimen 
collection, and medical record abstraction. A case or control mother was sent a pre-contact 
letter informing them about the study, and two weeks later, an introductory packet 
comprised of an introductory letter, the family history questionnaire, a fact sheet/rights as a 
research subject, a frequently asked questions sheet, and $10 reimbursement was mailed. A 
systematic follow-up protocol was used to encourage return of a completed family history 
questionnaire. Following receipt of a completed questionnaire, a case or control mother was 
sent a saliva specimen collection kit comprised of: a specimen collection letter and 
instructions; written consent forms for mother and father; specimen collection supplies for 
mother, father and child; $20 reimbursement; and a medical release form (case mothers 
only). Again, a systematic follow-up protocol was used to encourage return of saliva 
specimens and for case mothers, a medical release form. Once a family returned the saliva 
specimens, a thank you letter and $20 were sent to the mother. For case mothers who 
returned a signed medical record release form, medical record abstraction for postnatal 
events, including request for computed tomographic cranial images, was completed. The 
study protocol was approved by the Icahn School of Medicine at Mount Sinai, The 
University of Iowa and New York State Department of Health institutional review boards, 
and conformed to the guidelines set forth by the Declaration of Helsinki.
Mutation Screening
Candidate genes or mutations were selected based on their known involvement in human 
sagittal craniosynostosis, in animal models, and/or expression studies related to sagittal 
suture development. In addition to selected variants in FGFR1 (c.1508C>T), FGFR2 (c.833 
G>A; c.943 G>A), FGFR3 (c.749C>G; c.1000 G>A) (Table 2), and the TWIST1 gene, we 
also included in our screen two new candidate genes: RAB23, which is responsible for 
Carpenter syndrome, which presents with midline sagittal, as well as metopic, synostosis, 
and BMP2, which was identified from the previously mentioned GWAS study.11 DNA 
sequence analysis was performed on 93 affected sNSC cases. Primers for the coding regions 
of all candidate genes or variants (FGFR1 NM_023105; FGFR2 NM_000141; FGFR3 
NM_000142.2; TWIST1 NM_000474; RAB23 NM_183227; BMP2 NM_001200) were 
designed using Primer 3 (http://bioinfo.ut.ee/primer3-0.4.0/) (see Supplemental Digital 
Content 1, Table shows sequencing primers for candidate genes, INSERT LINK). The 
sequencing was conducted by Genewiz Inc (http://www.genewiz.com/) and sequences 
analyzed using Sequencher software (v4.8; Gene Codes Corporation, Ann Arbor, MI). We 
initially screened only the case child. When a variant was identified, we sequenced maternal 
DNA specimens, and if available, paternal DNA specimens to determine if the variant was 
de novo or segregated within the family. To confirm the variation, we carried out molecular 
analysis of 58 healthy children, or 116 control alleles, and compared our results to the 1000 
Genomes Project (1KG) database (http://browser.1000genomes.org), the NHLBI Grand 
Opportunity Exome Sequencing Project (ESP) database (http://evs.gs.washington.edu/
EVS/), the Exome Aggregation Consortium (ExAC) database (http://
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exac.broadinstitute.org/) and Locus Specific Mutation Database (LSDB) (http://
grenada.lumc.nl/LSDB_list/lsdbs).
RESULTS
Among the 93 affected sNSC cases screened, we identified two rare novel coding variants in 
our case child sample. These variants included a heterozygous c.439C>G transversion in 
TWIST1 exon 1 (Fig. 1), which predicted a glutamine-to-glutamic acid transition that 
occurred within the highly conserved loop domain. This variant was also present in the case 
child’s mother, who had an undefined jaw anomaly with corrective surgery when she was a 
teenager. The other heterozygous variant, c.730_731insG (NM_023105), was observed in 
exon 6 in FGFR1 in a different case child (Fig. 1), but not in the case child’s mother; a 
specimen was not available for the case child’s father to be able to determine if this variant 
was a de novo variant. This insertion was predicted to abolish the entire immunoglobin III 
domain, including the ligand binding region. These two variants were not seen in the 1KG, 
ESP or LSDB databases, however the TWIST1 variant c.439C>G was found in an extremely 
low frequency in ExAC database (1 in 120318 alleles, phenotypic information unavailable). 
In addition, we identified a heterozygous variant, c.546A>C, in RAB23 in a third case child; 
this variant predicted the amino acid substitution of glutamic acid to aspartic acid. There is 
not sufficient extant data in the literature to predict a functional effect of this variant from 
evolutionary conservation using Mutation Assessor tool.12 The case child’s unaffected 
mother carried the same variant with no obvious phenotype, and this rare variant was also 
found in one individual from the NHLBI ESP database. It is unknown if the carrier from 
ESP had any relevant phenotype. Also we did not find any of the previously reported 
variants in FGFR1-3, TWIST1, RAB23 and BMP2 in our study samples (Table 2).
DISCUSSION
Using a population-based sample, we identified a very rare variant glutamine-to-glutamic 
acid transition in exon 1 in TWIST1 (c.439C>G; Fig. 1). The assessment of the functionality 
of this variant made by the Mutation Assessor tool is presented in Figure 2 and Figure 3.12 
From multiple sequence alignment, we concluded that the variant residue occupies one of 
the top specificity positions (Fig. 2) and contributes to the complex formation between 
transcriptional regulator TWIST1 and the transcriptional factor E2 alpha (Fig. 3). 
Interestingly, both types of the variant residues, the original glutamine and variant glutamic 
acid are present in specific subfamilies. This suggests that the glutamic acid variant may be 
responsible for the specific regulation of the DNA transcription, biologically different from 
the one performed by the common glutamine variant of the TWIST1. We believe this variant 
to be pathogenic based on the following evidence. First, this variant was located within the 
highly conserved loop domain, which is important for the TWIST1 protein’s tertiary 
structure and dimerization. A number of mutations, including c.435G>C and c.443C>A, 
have been detected in different Saethre-Chotzen patients within the coding sequence for the 
loop domain at the surrounding nucleotide positions and were confirmed to be 
deleterious.13,14 Second, the variant was extremely rare in the general population. It was 
absent in a panel of 116 normal control alleles and two of the largest human genome 
databases; and it was found only once in more than 6000 individuals in ExAC database and 
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the individual information is unknown. The low frequency of the variant could not exclude 
its pathogenicity. In previous studies, some mutations which were found in other large 
cohorts of sNSC patients or confirmed with functional analysis also showed a very low 
population frequency in the public databases (Table 2). Lastly, the variant was found in both 
the case child and mother. Although the mother had no features of obvious craniosynostosis, 
she was reported to have anomalous jaw formation, another developmental bone 
abnormality. TWIST1, a helix-loop-helix transcription factor, has been implicated both in 
Saethre-Chotzen syndrome and in nonsyndromic coronal craniosynostosis.10,15 However, 
detected point mutations in TWIST1 have been implicated in very few cases of sNSC (Table 
2) and are likely to contribute to very few patients. Variable phenotypic expressivity in 
patients with TWIST1 mutations is common. A S188L mutation in the TWIST Box domain 
was previously identified to be pathogenic both in a patient with sNSC and the patient’s 
father, who had only small, square-shaped ears and is considered to represent a very mild 
manifestation of the TWIST1 mutation.16 Similarly in our study, the mother might have 
variable expressivity of the phenotype with only jaw defects. In the Twist1+/− mice, sagittal 
suture closure was found to be related to the canonical Wnt signaling downregulation and 
the causative effects for sNSC are most likely of an epigenetic nature.17
Few FGFR1 mutations have been associated with craniosynostosis. A specific mutation 
P252R in Pfeiffer syndrome and a heterozygous FGFR1 I300L were found in a 
trigonocephaly patient with isolated metopic synostosis.18 With our population-based 
sample, we also screened the previously reported FGFR1 c.1508C>T variant,16 but failed to 
detect the same variant in our study sample. Instead, we identified another novel variant, c.
730_731insG, near the c. 1508C>T variant, which led to a premature stop codon 
(p.A244fs*26) and was predicted to abolish the entire IgIII domain, including the ligand 
binding region. The function of c.730_731insG needs to be further studied. Gain-of-function 
mutations in FGFR2 have been identified in a majority of autosomal dominant 
craniosynostosis syndromes that usually include the coronal suture, but multiple affected 
sutures (coronal and sagittal) can also be involved in some complex cases. In addition to the 
mutation hotspots found in syndromic craniosynostosis, a few FGFR2 mutations have been 
reported in different patients with nonsyndromic sagittal craniosynostosis (Table 2). In 
contrast to FGFR2, only four mutations in FGFR3 have been identified in patients with 
craniosynostosis, P250R mutation in Muenke syndrome, A391E in Crouzon syndrome with 
acanthosis nigricans, P250L in one family with nonsyndromic craniosynostosis (sutures 
involved were unknown), and A334T in a family with mild sagittal crainosynostosis.3,19,20 
A complete screening of FGFR3 was undertaken in 97 craniosynostosis patients with no 
known molecular defect and no causative mutation was identified.15 Our screening for 
FGFR2 C278Y and A315T variants and the FGFR3 mutation hotspots P250R and A334T 
failed to identify any novel sequence variants in either gene.
Carpenter syndrome is a rare craniosynostosis syndrome with midline sagittal suture 
involvement. Presumed loss-of-function mutations were found in RAB23, which encodes a 
member of the RAB guanosine triphosphatase family of vesicle transport proteins and acts 
as a negative regulator of hedgehog signaling. We screened the entire RAB23 and BMP2 
coding and flanking regions in our study sample, but failed to identify any novel sequence 
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variants in either gene. Our study is also the first population-based cohort that demonstrates 
that mutations in several genes associated with currently known or identified 
craniosynostosis usually associated with coronal craniosynostosis, were not common in our 
sNSC cases. Our sequencing results were consistent with the data from previous reports in 
non-population, Caucasian cohorts.2,3,11 Thus, sNSC remains a heterogeneous and 
challenging disorder. Furthering knowledge of gene variants that produce craniosynostosis 
will require identifying functional variants, investigating pathway and other interactions by 
using whole exome/genome sequencing, and conducting genome-wide association studies to 
identify genetic interactions that may reveal critical genetic relationships that modify 
craniosynostosis phenotypes.
CONCLUSIONS
The etiology of sNSC is complex and is yet unknown. Our sequencing results of a 
population-based cohort of sNSC patients indicate that the FGFR1-3 mutational hotspots, 
TWIST1, RAB23 and BMP2 gene coding regions which are involved in syndromic sagittal 
craniosynostosis and/or sagittal nonsyndromic craniosynostosis contribute to only a few 
cases of sNSC (variant detection frequency about 1%). Additional studies are needed to 
elucidate the pathological mechanisms underlying sNSC since these candidate genes may 
not be the major causes of sNSC and genetic testing of these genes was negative in most 
cases.
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Fig. 1. 
Sequencing chromatogram of novel variants identified in this study. The arrows indicate the 
positions of the variants. (Left) TWIST1 c.439C>G; (Right) FGFR1 c.730_731insG.
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Fig. 2. 
Assessment of the functional impact of the variant p.Q147E (c.439 C>G) in TWIST1. A 
reduced presentation of the multiple sequence alignment of the protein region with mutated 
residue produced by Mutation Assessor.12 The whole alignment is composed of 393 
sequence homologs of TWIST1 (both human and non-human) and divided into 29 
subfamilies; only 50 sequences and 4 subfamilies are shown. The positions in the alignment 
are assessed by evolutionary conservation within entire protein family and by specificity, i.e. 
evolutionary conservation within subfamilies; the lengths of the bars above the alignment 
represent the relative strength of conservation and specificity in positions of the multiple 
alignment. The residues, which are conserved within subfamilies, i.e. specific to the 
subfamilies, are typically responsible for the actual binding specificity of proteins. The 
mutated residue is located in one of the top specificity positions, both the original glutamine 
and the mutated glutamic acid residues are represented by subfamilies; however the 
dominant residue in this position is a glutamic acid.
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Fig. 3. 
The 3D view of the complex of the neurogenic differentiation factor 1 (mouse homolog of 
TWIST1) and the transcription factor E2-alpha bound to DNA (PDB code 2QL2). The 
conserved and the specificity residues derived from multiple sequence alignment of 
TWIST1 homologs are mapped on the 3D structure of the neurogenic differentiation factor 1 
and shown in blue and orange, respectively; DNA fragment is shown in violet; an alpha-
helix fragment of E2-alpha is shown in green. The glutamic acid E147 in the position of the 
mutated residue (shown in dark red) contributes to the complex formation by interacting 
with the charged residues of the arginine 600 and the main chain of the glutamic acid 601 of 
E2-alpha protein; it also interacts with the hydroxyl group of serine 138 of TWIST1. The 
mutation of the glutamine Q147 to glutamic acid in TWIST1 is predicted to affect the 
stability, the complex and the regulation of transcription performed by TWIST1 molecule.
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